Browse > Article
http://dx.doi.org/10.5223/pghn.2013.16.3.178

Pre-diagnostic Clinical Presentations and Medical History Prior to the Diagnosis of Inflammatory Bowel Disease in Children  

Kwon, Yong Hoon (Department of Pediatrics, Hanyang University College of Medicine)
Kim, Yong Joo (Department of Pediatrics, Hanyang University College of Medicine)
Publication Information
Pediatric Gastroenterology, Hepatology & Nutrition / v.16, no.3, 2013 , pp. 178-184 More about this Journal
Abstract
Purpose: The clinical presentations of inflammatory bowel disease (IBD) prior to diagnosis are so diverse or vague that many of them waste time before final diagnosis. This study was undertaken to know the medical history of the pediatric patients until the final diagnosis could be reached. Methods: The medical records of all pediatric patients who were diagnosed with IBD (Crohn's disease [CD] in 14 children, ulcerative colitis [UC] in 17) during the last 13 years were reviewed. We investigated the length of the diagnostic time lag, chief clinical presentation, and any useful laboratory predictor among the routinely performed examinations. Indeterminate colitis was not included. Results: The mean ages of children at the final diagnosis was similar in both diseases. As for the pre-clinical past history of bowel symptoms in CD patients, 5 were previously healthy, 9 had had 1-3 gastrointestinal (GI) symptoms, weight loss, bloody stool, anemia and rectal prolapse. With UC, 9 were previously healthy, 8 had had 1-3 GI symptoms, bloody stool, anorexia. The average diagnostic time lag with CD was 3.36 months, and with UC 2.2 months. Body mass index (BMI) and the initial basic laboratory data (white blood cell, hemoglobin, mean corpuscular volume, serum albumin, and serum total protein) were lower in CD, statistically significant only in BMI. Conclusion: IBD shows diverse clinical symptoms before its classical features, making the patients waste time until diagnosis. It is important to concern possibility of IBD even in the mildly sick children who do not show the characteristic symptoms of IBD.
Keywords
Inflammatory bowel diseases; Child;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Saro Gismera C, Riestra Menendez S, Sanchez Fernandez R, Milla Crespo A, Lacort Fernandez M, Argüelles Fernández G, et al. Epidemiology in inflammatory bowel disease in five areas of Asturias. Spain. An Med Interna 2003;20:232-8.
2 Lee JH. Inflammatory bowel disease in pediatric age. Korean J Pediatr Gastroenterol Nutr 2011;14(Suppl 1):S34-41.   DOI
3 Benchimol EI, Guttmann A, Griffiths AM, Rabeneck L, Mack DR, Brill H, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut 2009;58:1490-7.   DOI
4 Yesil A, Senateş E, Bayoglu IV, Erdem ED, Demirtunc R, Kurdas Ovünc AO. Red cell distribution width: a novel marker of activity in inflammatory bowel disease. Gut Liver 2011;5:460-7.   DOI
5 Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol 2011;46:304-9.   DOI
6 Mijac DD, Jankovic GL, Jorga J, Krstic MN. Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. Eur J Intern Med 2010;21: 315-9.   DOI
7 Hebuterne X, Filippi J, Al-Jaouni R, Schneider S. Nutritional consequences and nutrition therapy in Crohn's disease. Gastroenterol Clin Biol 2009;33(Suppl 3):S235-44.   DOI
8 Mullin GE. Micronutrients and inflammatory bowel disease. Nutr Clin Pract 2012;27:136-7.   DOI
9 Savoye G, Salleron J, Gower-Rousseau C, Dupas JL, Vernier-Massouille G, Fumery M, et al. Clinical predictors at diagnosis of disabling pediatric Crohn's disease. Inflamm Bowel Dis 2012;18:2072-8.   DOI
10 Porter CK, Cash BD, Pimentel M, Akinseye A, Riddle MS. Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol 2012;12:55.   DOI
11 Mearin F, Perelló A, Balboa A. Irritable bowel syndrome and inflammatory bowel disease: Is there a connection? Gastroenterol Hepatol 2009;32:364-72.   DOI
12 Garcia Rodríguez LA, Ruigomez A, Wallander MA, Johansson S, Olbe L. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol 2000;35:306-11.   DOI
13 Porter CK, Tribble DR, Aliaga PA, Halvorson HA, Riddle MS. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology 2008;135: 781-6.   DOI
14 Dilauro S, Crum-Cianflone NF. Ileitis: when it is not Crohn's disease. Curr Gastroenterol Rep 2010;12: 249-58.   DOI
15 Zhou ZY, Luo HS. Differential diagnosis between Crohn's disease and intestinal tuberculosis in China. Int J Clin Pract 2006;60:212-4.   DOI
16 Jin XJ, Kim JM, Kim HK, Kim L, Choi SJ, Park IS, et al. Histopathology and TB-PCR kit analysis in differentiating the diagnosis of intestinal tuberculosis and Crohn's disease. World J Gastroenterol 2010;16: 2496-503.   DOI
17 Saro Gismera C, Lacort Fernandez M, Argüelles Fernandez G, Anton Magarzo J, Navascues CA, Garcia Lopez R, et al. Epidemiology of chronic inflammatory bowel disease in Gijon, Asturias. Gastroenterol Hepatol 2001;24:228-35.   DOI
18 van Dijken TD, Vastert SJ, Gerloni VM, Pontikaki I, Linnemann K, Girschick H, et al. Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept. J Rheumatol 2011;38:1441-6.   DOI
19 Kokkonen J, Arvonen M, Vähäsalo P, Karttunen TJ. Intestinal immune activation in juvenile idiopathic arthritis and connective tissue disease. Scand J Rheumatol 2007;36:386-9.   DOI